An update on COVID-19 vaccine trials| Jonathan Wosen

<p>That urgent desire for a sense of safety and a return to normalcy has fueled an unprecedented search for a vaccine against the worst pandemic humanity has faced in a century.</p><p>CEOs of Pfizer and Moderna, two of the vaccine developers furthest along in that search, have said they could request emergency-use authorization for their COVID-19 vaccines by late November and December, respectively, depending on results from trials that have enrolled tens of thousands of volunteers (including <a href="https://go.sandiegouniontribune.com/trials-of-the-century/p/1" target="_blank">San Diegans</a>).</p><p>On Wednesday, Health and Human Services secretary Alex Azar <a href="https://www.youtube.com/watch?v=knAn8XV8-No&ab_channel=CBSThisMorning" target="_blank">said</a> there could be enough doses of a COVID-19 vaccine for those most vulnerable to the disease by the end of 2020, with enough vaccine for all Americans by early April.</p><p><br /></p><p>Read more: <a href="https://www.sandiegouniontribune.com/news/health/story/2020-10-25/were-getting-closer-to-having-a-covid-19-vaccine-hold-onto-that-mask" target="_blank">https://www.sandiegouniontribune.com/news/health/story/2020-10-25/were-getting-closer-to-having-a-covid-19-vaccine-hold-onto-that-mask</a></p><p>Also: <a href="https://go.sandiegouniontribune.com/trials-of-the-century/p/1" target="_blank">https://go.sandiegouniontribune.com/trials-of-the-century/p/1</a></p>